Position in RCKT
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$18,285,594
-$129,090 QoQ
Shares Held
5,107,708
-2.6% QoQ
Ownership
4.68%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RCKT Over Time
Shares Held
Position Value (USD)
Derivatives in RCKT
reported options exposure · as of Mar 31, 2025CallValue
$399,533
CallShares
59,900
PutValue
$399,533
PutShares
59,900
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026CITIGROUP INC holds $1,427,117,007 across 402 Biotechnology names. RCKT ranks #17 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
682,807 | $304,900,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
184,691 | $142,699,654 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
263,375 | $87,142,884 | |
| 4 | MRNA |
Moderna, Inc.
|
1,480,034 | $75,185,727 | |
| 5 | FOLD |
AMICUS THERAPEUTICS, INC.
|
4,226,882 | $61,120,713 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
746,483 | $55,433,827 | |
| 7 | INCY |
Incyte Corp
|
489,649 | $46,085,763 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,536,110 | $42,550,246 |
All Filings in RCKT
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $18,285,594 | 5,107,708 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $18,414,684 | 5,246,349 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $33,984 | 10,425 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $362,670 | 148,029 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $399,533 | 59,900 | Put | Defined | 2025-05-12 | |
| 2025-03-31 | $399,533 | 59,900 | Call | Defined | 2025-05-12 | |
| 2025-03-31 | $1,561,965 | 234,178 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $1,551,326 | 123,415 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $951,129 | 51,496 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $733,957 | 34,090 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $7,681,751 | 285,143 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $2,704,910 | 90,254 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $3,301,245 | 161,115 | Shares | Defined | 2023-12-06 | |
| 2023-06-30 | $1,709,694 | 86,044 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $4,278,559 | 249,770 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $2,633,221 | 134,554 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $5,377,959 | 336,965 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $5,625,018 | 408,795 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $720,487 | 45,428 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $3,030,113 | 138,805 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $2,424,945 | 81,129 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $4,960,523 | 112,001 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $3,839,778 | 86,540 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $681,057 | 12,419 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $107,532 | 4,704 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $578,316 | 27,631 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $308,643 | 22,125 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||